Search Beyond News…

Aignostics launches PathoSearch, an AI‑powered visual search engine that gives pathologists instant access to over 300 diagnosed reference cases from top medical centers

Executive summary: Aignostics announced the early‑access launch of PathoSearch, a visual search engine for pathology that provides image‑based retrieval of more than 300 diagnosed reference cases from leading medical centers. The tool can shorten the time pathologists spend searching for reference slides, promote more consistent case interpretation, and create a new revenue stream for Aignostics through licensing or subscription models.

Who is involved: Aignostics (developer), world‑class pathology laboratories supplying the reference case library, and potential users such as hospital pathology departments and digital pathology platforms.

Likely next: After gathering early‑access feedback, Aignostics will likely pursue regulatory clearances (e.g., CE marking, FDA 510(k)) and seek integration deals with hospital information systems and PACS vendors to move toward a full commercial launch.

Aignostics has released an early‑access version of PathoSearch, a visual search tool that lets users upload pathology images and retrieve matching diagnosed cases from a library covering more than 300 diagnostic entities. The service draws on reference material from world‑class pathology centers in Berlin, New York and elsewhere, aiming to speed up case lookup and reduce variability in diagnostic workflows. By offering the tool in early access, the company seeks user feedback before a broader commercial rollout, while positioning itself in the growing market for AI‑assisted pathology solutions.

What's next — scenarios

Base: Steady adoption through early access feedback (50%)

Aignostics secures contracts with roughly fifty pathology labs within the first year, generating modest recurring revenue and validating the search engine’s utility.

Upside: Rapid expansion after regulatory clearance (30%)

Following CE marking or FDA approval, major hospital chains and reference labs adopt PathoSearch, driving double‑digit growth in the digital pathology AI segment.

Downside: Limited uptake due to privacy and reimbursement concerns (20%)

Adoption stalls below twenty sites, pushing Aignostics to rely on research‑only licenses and delaying monetization.

Timeline

Analysis — what this means

Sectors affected

Key entities

Sources

Related cases

Browse the full archive →